Literature DB >> 19554003

Stroke: Atrial fibrillation, stroke prevention therapy and aging.

J David Spence.   

Abstract

Stroke risk in patients with nonvalvular atrial fibrillation increases markedly with age. although anticoagulation is more effective than antiplatelet therapy in atrial fibrillation, it tends to be underutilized in the elderly. A study by van Walraven et al. examines the influence of age on stroke prevention therapy in atrial fibrillation.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19554003     DOI： 10.1038/nrcardio.2009.98

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  10 in total

Review 1.  The endothelium, platelets, and brain ischemia.

Authors:  Louis R Caplan; Mark Fisher
Journal:  Rev Neurol Dis       Date:  2007

Review 2.  Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development.

Authors:  Bengt I Eriksson; Daniel J Quinlan; Jeffrey I Weitz
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

3.  Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.

Authors:  Carl van Walraven; Robert G Hart; Stuart Connolly; Peter C Austin; Jonathan Mant; F D Richard Hobbs; Peter J Koudstaal; Palle Petersen; Francisco Perez-Gomez; J Andre Knottnerus; Beppie Boode; Michael D Ezekowitz; Daniel E Singer
Journal:  Stroke       Date:  2009-01-29       Impact factor: 7.914

4.  Disparate stroke rates on warfarin among contemporaneous cohorts with atrial fibrillation: potential insights into risk from a comparative analysis of SPORTIF III versus SPORTIF V.

Authors:  Elaine M Hylek; Lars Frison; Lori E Henault; Adrienne Cupples
Journal:  Stroke       Date:  2008-08-14       Impact factor: 7.914

5.  Population rates of hospitalization for atrial fibrillation/flutter in Canada.

Authors:  Karin H Humphries; Cynthia Jackevicius; Yanyan Gong; Larry Svensen; Jafna Cox; Jack V Tu; Andreas Laupacis
Journal:  Can J Cardiol       Date:  2004-07       Impact factor: 5.223

Review 6.  Vitamin B12 (cobalamin) deficiency in elderly patients.

Authors:  Emmanuel Andrès; Noureddine Henoun Loukili; Esther Noel; Georges Kaltenbach; Maher Ben Abdelgheni; Anne Elisabeth Perrin; Marie Noblet-Dick; Frédéric Maloisel; Jean-Louis Schlienger; Jean-Frédéric Blicklé
Journal:  CMAJ       Date:  2004-08-03       Impact factor: 8.262

7.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

Review 8.  Homocysteine-lowering therapy: a role in stroke prevention?

Authors:  J David Spence
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

9.  Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.

Authors:  David J Gladstone; Esther Bui; Jiming Fang; Andreas Laupacis; M Patrice Lindsay; Jack V Tu; Frank L Silver; Moira K Kapral
Journal:  Stroke       Date:  2008-08-28       Impact factor: 7.914

10.  Genetic determinants of response to warfarin during initial anticoagulation.

Authors:  Ute I Schwarz; Marylyn D Ritchie; Yuki Bradford; Chun Li; Scott M Dudek; Amy Frye-Anderson; Richard B Kim; Dan M Roden; C Michael Stein
Journal:  N Engl J Med       Date:  2008-03-06       Impact factor: 91.245
  10 in total
  6 in total

Review 1.  Calmodulin kinase II, sarcoplasmic reticulum Ca2+ leak, and atrial fibrillation.

Authors:  Dobromir Dobrev; Xander H T Wehrens
Journal:  Trends Cardiovasc Med       Date:  2010-01       Impact factor: 6.677

2.  Atrial fibrillation and stroke prevention: is warfarin still an option? Yes: Debate at the Controversies in Neurology Congress, Beijing, October 2011.

Authors:  J David Spence
Journal:  J Neural Transm (Vienna)       Date:  2012-12-12       Impact factor: 3.575

3.  Neuroprotective effect of combined hypoxia-induced VEGF and bone marrow-derived mesenchymal stem cell treatment.

Authors:  Sung Su An; Hong Lian Jin; Keung Nyun Kim; Dong Seok Kim; Joon Cho; Meng-Lu Liu; Jin Soo Oh; Do Heum Yoon; Min Hyung Lee; Yoon Ha
Journal:  Childs Nerv Syst       Date:  2010-03       Impact factor: 1.475

Review 4.  Secondary stroke prevention.

Authors:  J David Spence
Journal:  Nat Rev Neurol       Date:  2010-08-10       Impact factor: 42.937

Review 5.  Antithrombotic therapy in very elderly patients with atrial fibrillation: is it enough to assess thromboembolic risk?

Authors:  Yutao Guo; Qiang Wu; Lu Zhang; Tingshu Yang; Ping Zhu; Wenqian Gao; Yuexiang Zhao; Meng Gao
Journal:  Clin Interv Aging       Date:  2010-05-25       Impact factor: 4.458

Review 6.  Intensive risk factor control in stroke prevention.

Authors:  J David Spence
Journal:  F1000Prime Rep       Date:  2013-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.